Tyrosine kinase receptor TYRO3 as a therapeutic target in the treatment of cancer
US9233144B2 · kind B2 · utility
2Cited by
0References
23Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Sep 18, 2009 |
| Grant date | Jan 12, 2016 |
| Priority date | — |
| Expiry date | Sep 18, 2029 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2500/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention concerns new methods for treating cancer by using TYRO3 inhibitors and methods for identifying new molecules of interest for treating cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.